MedTrace Logo

Refractory IHCA and OHCA Treated With ECMO

NCT01298050 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2011-08-04

No results posted yet for this study

Summary

Extracorporeal membrane oxygenation (ECMO) support has been suggested to improve the survival rate in patients with refractory cardiac arrest (CA). Recent studies have also highlighted the potential early application of this method in improving the prognosis of prolonged cardiac arrest both for in hospital CA (INHCA) and out of hospital CA (OHCA). The rationale for use of ECMO in these patients is to optimize early perfusion of vital organs, curing the cause of CA and waiting for the recovery of the injured myocardium. The investigators have created a flow-chart to decide which patients are eligible. The aims of this study are to evaluate if, with this flow-chart, the investigators are able to detect which patients have more probability of survival.

Conditions

  • Cardiac Arrest

Interventions

PROCEDURE

ECMO

Insertion of peripheral Veno-Arterious ECMO, subsequent therapeutic hypothermia

Sponsors & Collaborators

  • Ospedale San Gerardo. S.S.U.E.M. 118 Brianza

    collaborator UNKNOWN

  • Ospedale San Gerardo. Terapia Intensiva Cardiochirurgica

    collaborator UNKNOWN

  • University of Milano Bicocca

    lead OTHER

Principal Investigators

  • Leonelllo Avalli, MD · Ospedale San Gerardo

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-07-31
Completion
2013-07-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01298050 on ClinicalTrials.gov